Heather Lounsbury

Clinical Development of AVL-292; A Potent, Selective Covalent Btk Inhibitor for the Treatment of B Cell Malignancies,

Juswinder Singh, S. Ponader, M. Nacht, 2011 .

Inhibition of Btk with CC-292 Provides Early Pharmacodynamic Assessment of Activity in Mice and Humans

Juswinder Singh, M. Nacht, R. Petter, 2013, The Journal of Pharmacology and Experimental Therapeutics.

Phase Ib trial of AVL-292, a covalent inhibitor of Bruton's tyrosine kinase (Btk), in chronic lymphocytic leukemia (CLL) and B-non-Hodgkin lymphoma (B-NHL).

Juswinder Singh, T. Kipps, J. Gabrilove, 2012 .

The ECG in Environmental Urgencies and Emergencies

Heather Lounsbury, S. Althoff, H. Lounsbury, 2020 .